Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation

• Published in: Pathology international Vol. 71; no. 1; pp. 15 - 23
• Main Authors: Sanoyama, Itaru, Sakurai, Yasutaka, Ichinoe, Masaaki, Hoshino, Akiyoshi, Kesen, Yurika, Kato, Takuya, Numata, Yoshiko, Umezawa, Atsuko, Jiang, Shi‐Xu, Murakumo, Yoshiki
• Format: Journal Article
• Language: English
• Published: Australia Wiley Subscription Services, Inc 01.01.2021
• Subjects: Apoptosis; Biological activity; Carcinogenesis; Carcinogens; Cell cycle; Cell growth; Cell proliferation; Cell survival; Chemoradiotherapy; Damage tolerance; Deoxyribonucleic acid; Depletion; DNA; DNA damage; DNA polymerase; DNA-directed DNA polymerase; Gene expression; immunohistochemistry; Lung cancer; Lung carcinoma; Medical prognosis; Metastases; Mutation; Prognosis; proliferation; REV7; siRNA; Small cell lung carcinoma; Survival; Tumors; apoptosis; REV7; immunohistochemistry; proliferation; small cell lung carcinoma
• ISSN: 1320-5463; 1440-1827
• DOI: 10.1111/pin.13040

REV7 is involved in multiple biological processes including DNA damage tolerance, cell cycle regulation and gene expression, and is an accessory subunit of the mutation‐prone DNA polymerase ζ. It has been reported that REV7 expression is associated with poor prognosis in several human cancers. The aim of this study is to investigate the significance of REV7 in lung carcinogenesis. Immunohistochemical analyses of surgically resected lung cancer specimens revealed that REV7 shows an increased expression in small cell lung carcinomas (SCLCs) when compared with other histological types of lung carcinoma. Association between REV7 expression levels and clinicopathological factors was investigated using SCLC cases with or without surgical resection. Our analyses revealed that high REV7 expression significantly correlated with tumor cell proliferation, assessed by Ki‐67 labeling indices, and was negatively associated with distant metastasis and extensive‐stage disease. No significant association was detected between REV7 expression and other factors, including prognosis or response to chemoradiotherapy in SCLC. Increase in REV7 expression in SCLC was confirmed using SCLC cell lines. In addition, siRNA‐mediated depletion of REV7 activated the apoptotic pathway and suppressed cell growth in SCLC cells. These results suggest that REV7 plays an important role in tumor cell survival and proliferation in SCLC.